UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 122

Sortiert nach

Three hundred robotic-assisted mitral valve repairs: The Cedars-Sinai experience

The Journal of thoracic and cardiovascular surgery, 2014, Vol.147 (1), p.228-235

2014

Volltextzugriff (PDF)

One-Year Efficacy and Safety of Evolocumab in Japanese Patients　― A Pooled Analysis From the Open-Label Extension OSLER Studies

Circulation Journal, 2017/06/23, Vol.81(7), pp.1029-1035

2017

Volltextzugriff (PDF)

Left Ventricular Reconstruction for Postinfarction Left Ventricular Aneurysm: Review of Surgical Techniques

Texas Heart Institute journal, 2017-10, Vol.44 (5), p.326-335

2017

Volltextzugriff (PDF)

Improving the Ability to Write Persuasive Texts in a Boy with Autism Spectrum Disorder: Outcomes of an Intervention

Brain sciences, 2020-04, Vol.10 (5), p.264

2020

Volltextzugriff (PDF)

Long-Term Treatment With Evolocumab Among Japanese Patients　― Final Report of the OSLER Open-Label Extension Studies

Circulation Journal, 2019/04/25, Vol.83(5), pp.971-977

2019

Volltextzugriff (PDF)

Age–gender considerations on survival in patients undergoing radial artery grafting

European journal of cardio-thoracic surgery, 2015-03, Vol.47 (3), p.583-583

Ruzza, Andrea

2015

Volltextzugriff (PDF)

Is gender-specific survival in patients undergoing radial artery grafting influenced by hormone levels?

The Journal of thoracic and cardiovascular surgery, 2013-06, Vol.145 (6), p.1687-1688

2013

Volltextzugriff (PDF)

Are Different Mechanical Circulatory Support Devices Important Factors Maximizing Patient Survival After Heart Transplant?

The Annals of thoracic surgery, 2013-10, Vol.96 (4), p.1530-1531

2013

Volltextzugriff (PDF)

Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia. Reply

The New England journal of medicine, 2021-01, Vol.384 (1), p.84-85

2021

Volltextzugriff (PDF)

Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia

The New England journal of medicine, 2020-10, Vol.383 (14), p.1317-1327

2020

Volltextzugriff (PDF)

Long-Term Efficacy and Safety of Evolocumab in Patients With Hypercholesterolemia

Journal of the American College of Cardiology, 2019-10, Vol.74 (17), p.2132-2146

2019

Volltextzugriff (PDF)

Nonpsychotic mental disorder after open heart surgery

Asian cardiovascular & thoracic annals, 2014-03, Vol.22 (3), p.374-374

Ruzza, Andrea

2014

Volltextzugriff (PDF)

Cognition After Lowering LDL-Cholesterol With Evolocumab

Journal of the American College of Cardiology, 2020-05, Vol.75 (18), p.2283-2293

2020

Volltextzugriff (PDF)

Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia

The New England journal of medicine, 2021-01, Vol.384 (1), p.84-85

2021

Volltextzugriff (PDF)

Cardiovascular Benefit of Lowering LDL Cholesterol Below 40 mg/dl

Circulation (New York, N.Y.), 2021-08, Vol.144 (21), p.1732-1734

2021

Volltextzugriff (PDF)

Cardiovascular Benefit of Lowering Low-Density Lipoprotein Cholesterol Below 40 mg/dL

Circulation (New York, N.Y.), 2021-11, Vol.144 (21), p.1732-1734

2021

Volltextzugriff (PDF)

Effect of evolocumab on acute arterial events across all vascular territories : results from the FOURIER trial

European heart journal, 2021-12, Vol.42 (47), p.4821-4829

2021

Volltextzugriff (PDF)

eComment. How to maintain sinus rhythm in patients with atrial fibrillation after atrium ablation?

Interactive cardiovascular and thoracic surgery, 2013-05, Vol.16 (5), p.594-594

Ruzza, Andrea

2013

Volltextzugriff (PDF)

EVOLOCUMAB IN PEDIATRIC HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: RESULTS FROM THE HAUSER OPEN-LABEL EXTENSION STUDY

Journal of the American College of Cardiology, 2022-03, Vol.79 (9), p.1476

2022

Volltextzugriff (PDF)

Evolocumab Treatment in Pediatric Patients With Homozygous Familial Hypercholesterolemia: Pooled Data From Three Open-Label Studies

Arteriosclerosis, thrombosis, and vascular biology, 2024-05, Vol.44 (5), p.1156

2024

Volltextzugriff (PDF)

Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial

The American heart journal, 2024-03, Vol.269, p.179-190

2024

Volltextzugriff (PDF)

Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT

The lancet. Diabetes & endocrinology, 2022-10, Vol.10 (10), p.732-740

2022

Volltextzugriff (PDF)

eComment. Is adventitial dissection enough as a simple and effective way to reduce radial artery spasm?

Interactive cardiovascular and thoracic surgery, 2013-11, Vol.17 (5), p.789-789

2013

Volltextzugriff (PDF)

How to maintain sinus rhythm in patients with atrial fibrillation after atrium ablation?

Interactive cardiovascular and thoracic surgery, 2013-05, Vol.16 (5), p.594-594

Ruzza, Andrea

2013

Volltextzugriff (PDF)

Evolocumab in patients with homozygous familial hypercholesterolemia in India

Journal of clinical lipidology, 2021-11, Vol.15 (6), p.814-821

2021

Volltextzugriff (PDF)

1 – 25 von 122

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(111)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Three hundred robotic-assisted mitral valve repairs: The Cedars-Sinai experience

One-Year Efficacy and Safety of Evolocumab in Japanese Patients　― A Pooled Analysis From the Open-Label Extension OSLER Studies

Left Ventricular Reconstruction for Postinfarction Left Ventricular Aneurysm: Review of Surgical Techniques

Improving the Ability to Write Persuasive Texts in a Boy with Autism Spectrum Disorder: Outcomes of an Intervention

Long-Term Treatment With Evolocumab Among Japanese Patients　― Final Report of the OSLER Open-Label Extension Studies

Age–gender considerations on survival in patients undergoing radial artery grafting

Is gender-specific survival in patients undergoing radial artery grafting influenced by hormone levels?

Are Different Mechanical Circulatory Support Devices Important Factors Maximizing Patient Survival After Heart Transplant?

Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia. Reply

Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia

Long-Term Efficacy and Safety of Evolocumab in Patients With Hypercholesterolemia

Nonpsychotic mental disorder after open heart surgery

Cognition After Lowering LDL-Cholesterol With Evolocumab

Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia

Cardiovascular Benefit of Lowering LDL Cholesterol Below 40 mg/dl

Cardiovascular Benefit of Lowering Low-Density Lipoprotein Cholesterol Below 40 mg/dL

Effect of evolocumab on acute arterial events across all vascular territories : results from the FOURIER trial

eComment. How to maintain sinus rhythm in patients with atrial fibrillation after atrium ablation?

EVOLOCUMAB IN PEDIATRIC HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: RESULTS FROM THE HAUSER OPEN-LABEL EXTENSION STUDY

Evolocumab Treatment in Pediatric Patients With Homozygous Familial Hypercholesterolemia: Pooled Data From Three Open-Label Studies

Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial

Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT

eComment. Is adventitial dissection enough as a simple and effective way to reduce radial artery spasm?

How to maintain sinus rhythm in patients with atrial fibrillation after atrium ablation?

Evolocumab in patients with homozygous familial hypercholesterolemia in India

Suchergebnisse filtern